Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
Titel:
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
Auteur:
Ruff, Christian T. Giugliano, Robert P. Antman, Elliott M. Crugnale, Sharon E. Bocanegra, Tomas Mercuri, Michele Hanyok, James Patel, Indravadan Shi, Minggao Salazar, Dan McCabe, Carolyn H. Braunwald, Eugene